Escare Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 86.17%
- Profit Growth 542.75%
- Ebitda 29.99%
- Net Worth 9.83%
- Total Assets 68.99%
About Escare Formulations
Escare Formulations Private Limited (EFPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 June 1997 and has a history of 27 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Sanjay Garg and Babita Garg serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51900MH1997PTC108783
- Company No.
108783
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Escare Formulations Private Limited
Explore comprehensive data for Escare Formulations Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Escare Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Garg  | Director | 16-Jun-1997 | Current |
| Babita Garg | Director | 16-Jun-1997 | Current |
Financial Performance of Escare Formulations.
Escare Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 86.17% increase. The company also saw a substantial improvement in profitability, with a 542.75% increase in profit. The company's net worth moved up by a moderate rise of 9.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Escare Formulations?
In 2020, Escare Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹1.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2019 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Escare Formulations?
Unlock and access historical data on people associated with Escare Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Escare Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Escare Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Escare Formulations
Recent activity within the organization
- Annual General Meeting
Escare Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Escare Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge with State Bank Of India amounted to Rs. 1.00 M with Charge ID 100295910 was registered on 09 Oct 2019.
- Director Appointment
Sanjay Kumar Garg was appointed as a Director was appointed as a Director on 16 Jun 1997 & has been associated with this company since 27 years 11 months .
- Director Appointment
Babita Garg was appointed as a Director was appointed as a Director on 16 Jun 1997 & has been associated with this company since 27 years 11 months .
- Company Incorporation
Escare Formulations Private Limited was registered on 16 Jun 1997 with Roc Mumbai & aged 27 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Escare Formulations Private Limited?
Escare Formulations Private Limited was incorporated on 16 Jun 1997.
What is authorized share capital and paid-up capital of Escare Formulations Private Limited?
The authorized share capital of Escare Formulations Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Escare Formulations Private Limited?
Currently 2 directors are associated with Escare Formulations Private Limited.
- Sanjay Kumar Garg
- Babita Garg
What is the registered address of Escare Formulations Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Escare Formulations Private Limited is Office No. 2 A Wing Vastu Sidhi, Yogi Dham India, Kalyan West, Maharashtra, 421301.
What is the corporate identification number (CIN) and company number of Escare Formulations Private Limited?
The corporate identification number (CIN) of Escare Formulations Private Limited is U51900MH1997PTC108783 and the company number is 108783 as per Ministry of Corporate Affairs (MCA).
What is the official website of Escare Formulations Private Limited?
The Official website of Escare Formulations Private Limited is https://www.escare.co.in
What has been the recent revenue trend for Escare Formulations Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Escare Formulations Private Limited has risen by 86.17%.
What change has been observed in the net worth of Escare Formulations Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Escare Formulations Private Limited has experienced an upsurge of 9.83%.
What are the total open charges for Escare Formulations Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Escare Formulations Private Limited amount to ₹ 1.00 M.
When was the last Balance Sheet of Escare Formulations Private Limited filed with the ROC?
The most recent Balance Sheet for Escare Formulations Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records